Proteome Sciences PLC (PRM) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Proteome Sciences PLC Company Snapshot

Business Description:

Proteome Sciences PLC operates in the Commercial physical research sector. Proteome Sciences plc is engaged in biomarker research and development in applied proteomics, using techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. The Company's three geographic segments include: United Kingdom, Germany and the United States. The main focus of research is to address neurological, neurodegenerative, oncology and cardiovascular conditions and blood biomarkers in stroke, brain damage, organ transplant rejection and to discover Alzheimer disease. During the financial year ended December 31, 2010, the Company launched tandem mass tag (TMT) reagent for labeling of peptides (cysTMT), which provide benefits in the breadth and depth of proteome coverage. The company's subsidiaries include Proteome Sciences R&D Verwaltungs GmbH, Proteome Sciences R&D GmbH & Co. KG, Xzillion GmbH & Co. KG, Proteome Sciences, Inc., Veri-Q Inc. and Phenomics Limited. In our complete report available for purchase the company is compared to: Renovo Group PLC, Cyprotex PLC and Antisoma PLC.

Proteome Sciences PLC

Stock Performance Chart for Proteome Sciences PLC

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 39.50p
(Figures in Pounds Sterling)

1 Week	3.3%		13 Weeks	25.9%

4 Weeks	84.8%		52 Weeks	17.9%

Proteome Sciences PLC Key Data:

	Ticker:	PRM	Country:	UNITED KINGDOM

	Exchanges:	LON	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Ethical Drug Manufacturers

	2010 Sales	9,866,628 (Year Ending Jan 2011).	Employees:	39

	Currency:	Pounds Sterling	Market Cap:	75,908,101

	Fiscal Yr Ends:	December	Shares Outstanding:	192,172,408

	Share Type:	Ordinary	Closely Held Shares:	64,954,200

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.